国产成人精品白浆久久69

Introduction

In keeping with the 国产成人精品白浆久久69’s (国产成人精品白浆久久69) mission to define and promote evidence-based best practices in addiction prevention, treatment, remission, and recovery, 国产成人精品白浆久久69 Quality Improvement Council (QIC) sought to rigorously update and structure 国产成人精品白浆久久69’s Clinical Practice Guideline (CPG) methodology. The QIC recognized a need for 国产成人精品白浆久久69’s CPG methods to be more in line with international standards for CPGs such as:

• Establishing improved transparency
• Managing conflicts of interest
• Balancing guideline group composition
• Using a rigorous systematic review
• Establishing quality of evidence
• Determining the strength of recommendations
• Articulating recommendations clearly and succinctly
• Engaging stakeholder review
• Promoting diversity, equity, and inclusion · Establishing a process for CPG updates

Over a two-year process, 国产成人精品白浆久久69 worked to create this new methodology which will inform how future 国产成人精品白浆久久69 CPGs are conducted.

Download

The methodology is available in two formats. For all methodology details and appendices, see the Full Methodology. For a summary document published in Journal of Addiction Medicine, see Summary Methodology.

Methodology

In January 2021, the 国产成人精品白浆久久69 QIC developed the “Clinical Practice Guideline Methodology and Oversight Subcommittee” and chose Dr. Melissa Weimer to lead this subcommittee. The CPG-MOS was charged with providing strategic oversight to the development, implementation, education, and communication of CPGs. The goals of the CPG-MOS were to establish and publish a methodology for the development of CPGs and to develop a CPG strategic plan.

Through an open call process, 国产成人精品白浆久久69 members were invited to apply for consideration to serve on the CPG-MOS subcommittee. The seven members chosen represent individuals from diverse backgrounds, geographies, research experience, and clinical backgrounds.

Each individual CPG methodology underwent evidence review, subcommittee deliberation, and consensus. The CPG-MOS subcommittee presented all proposed methodology for review, deliberation and approval to the 国产成人精品白浆久久69 QIC. When needed, other 国产成人精品白浆久久69 committees such as the 国产成人精品白浆久久69 Ethics Committee were engaged for review, deliberation and approval.

In the process of CPG methodology development, it became clear that other non-CPG clinical practice documents may be relevant for 国产成人精品白浆久久69 to develop. To promote best practices that remain evidence-based and can be more efficiently produced, the CPG-MOS and the QIC also developed a framework for new clinical documents described here as Clinical Guidance Statements and Clinical Considerations. These clinical documents will have less methodological rigor than the CPG, but will allow 国产成人精品白浆久久69 to respond in a timely manner to urgent clinical concerns from its members and the public.

The 国产成人精品白浆久久69 CPG Methodology will be reviewed every 5 years by the QIC for updates.

Authors: Members of the 国产成人精品白浆久久69 Clinical Practice Guideline Methodology and Oversight Subcommittee (CPG-MOS)

Chair: Melissa B. Weimer, DO, MCR, DF国产成人精品白浆久久69

Members: Emily Brunner, MD, DF国产成人精品白浆久久69, Devan Kansagara, MD, Todd Korthuis, MD, MPH, F国产成人精品白浆久久69, Lewis S. Nelson, MD, MBA, F国产成人精品白浆久久69, Darius Rastegar, MD, F国产成人精品白浆久久69, Audra Stock, MA, Carlos Tirado, MD, MPH, F国产成人精品白浆久久69

国产成人精品白浆久久69 Staff: Amanda Devoto, PhD, Taleen Safarian

Consultant: Bethea A. Kleykamp, PhD